Disc Medicine, Inc. logo IRON - Disc Medicine, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 10
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $90.00 DETAILS
HIGH: $90.00
LOW: $90.00
MEDIAN: $90.00
CONSENSUS: $90.00
UPSIDE: 8.87%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 46.9 45.9 46.2 50.3 46.3 27.8 24.8 24.7 23.5 23.7 22.6 14.4 12.1 20.2 20.6 7.9 7.7 7.8 12.6 13.5 10.8 11.8 0 6.7 5.5 8.2
SG&A Expenses 18.1 23.6 20.7 17.4 15.1 12.2 9.8 8.2 7.4 7.8 7.1 4.5 5.2 4.9 0.7 2.6 4.3 2.1 5.1 5.0 5.5 4.7 (0.5) 1.2 1.1 1.4
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (6.6) 0 0 0
Operating Expenses 65.1 69.5 67.0 67.7 61.4 39.9 34.5 32.9 30.9 31.5 29.7 19.0 17.3 25.1 21.3 10.5 12.0 10.0 17.7 18.4 16.3 16.5 (7.1) 7.9 6.7 9.6
Operating Income
Operating Income (65.1) (69.5) (67.0) (67.7) (61.4) (39.9) (34.5) (32.9) (30.9) (31.5) (29.7) (19.0) (17.3) (25.1) (21.3) (10.5) (12.0) (10.0) (17.7) (18.4) (16.3) (16.5) 7.1 (7.9) (6.7) (9.6)
Interest Expense 0.9 0.8 0.9 0.9 0.9 0.9 0 0 0 0 0 0 0 0 0.1 0.1 0.1 1.8 4.5 2.0 0.1 0.2
Interest Income 6.5 6.9 7.4 6.4 7.1 6.9 5.8 6.4 4.6 4.5 4.7 4.8 2.9 2.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0
Profitability
EBITDA (58.5) (62.5) (59.5) (61.2) (54.2) (33.0) (13.3) (26.5) (26.2) (26.9) (23.5) (14.1) (15.9) (22.7) (21.9) (16.1) (9.6) (9.8) (17.7) (18.4) (16.3) (17.1) 7.2 (7.9) (6.6) (9.5)
EBIT (58.6) (62.6) (59.6) (61.3) (54.3) (33.1) (13.3) (26.5) (26.3) (26.9) (23.5) (14.1) (15.9) (22.8) (22.0) (16.1) (9.6) (9.9) (17.7) (18.4) (16.3) (17.2) 7.1 (8.0) (6.7) (9.6)
Income Before Tax (59.5) (63.5) (60.4) (62.2) (55.2) (34.0) (29.3) (26.5) (26.3) (26.9) (23.5) (14.1) (15.9) (22.8) (21.2) (16.1) (9.6) (9.9) (17.8) (18.6) (16.4) (19.0) 9.2 (10.0) (6.8) (9.7)
Income Tax Expense 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (59.5) (63.5) (60.5) (62.3) (55.2) (34.1) (29.5) (26.6) (26.4) (26.9) (23.6) (14.1) (15.9) (22.8) (21.2) (16.1) (9.6) (9.9) (17.8) (18.6) (16.4) (19.0) 9.2 (10.0) (6.8) (9.7)
Per Share Data
EPS (Basic) -1.54 -1.65 -1.64 -1.77 -1.58 -1.02 -0.98 -0.89 -1.03 -1.09 -1.00 -0.58 -0.74 -1.20 -21.23 -16.82 -10.14 -10.67 -6.97 -4.30 -3.82 -5.95 -0.20 -6.44 -4.36 -6.27
EPS (Diluted) -1.54 -1.65 -1.64 -1.77 -1.58 -1.02 -0.98 -0.89 -1.03 -1.09 -1.00 -0.58 -0.74 -1.20 -21.23 -16.82 -10.14 -10.67 -6.97 -4.30 -3.82 -5.95 -0.20 -6.44 -4.36 -6.27
Shares Outstanding 38.7 38.5 35.3 35.2 35.0 33.3 29.9 29.9 25.6 24.8 23.6 24.3 21.5 19.0 1.0 1.0 0.9 0.9 2.6 4.3 4.3 3.2 1.6 1.6 1.6 1.6
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4
Current Assets
Cash & Cash Equivalents 98.7 88.9 91.1 140.7 127.3 122.7 192.4 192.6 280.7 342.6 360.4 370.5 377.6 236.4 194.6 101.7 108.7 119.1 88.0 150.1 167.5 185.0 4.5
Short-Term Investments 619.1 641.2 700.0 475.3 522.6 572.0 297.4 294.7 220.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Receivables 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 15.0 17.3 12.7 11.2 11.6 10.9 3.7 5.8 7.3 9.3 0 3.7 4.1 5.7 0 0 0 0.3 (0.8) 0 0 0 0
Total Current Assets 732.8 747.5 803.9 627.2 661.6 705.6 493.6 493.2 508.2 351.9 365.7 374.3 381.7 242.1 198.5 104.7 113.1 124.1 90.5 154.8 171.3 188.6 5.1
Non-Current Assets
Property, Plant & Equipment 1.8 2.0 2.3 2.4 2.6 2.8 2.3 1.8 1.7 2.0 2.1 2.1 2.3 1.5 1.6 0 0 0 1.7 0.2 0.2 0.2 0.3
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0.3 0 0
Other Non-Current Assets 0.5 0.7 0.7 0.8 0.8 0.8 0.8 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 1.4 0.2 0.2 0.2 0.2 0.6 0.5 3.0
Total Non-Current Assets 2.3 2.8 3.0 3.3 3.5 3.7 3.2 2.0 2.0 2.2 2.3 2.2 2.4 1.6 1.7 1.4 0.2 0.2 1.9 0.7 1.1 0.8 3.3
Total Assets 735.1 750.2 806.9 630.5 665.1 709.3 496.8 495.1 510.2 354.2 368.0 376.5 384.2 243.8 200.2 106.0 113.3 124.3 92.4 155.5 172.4 189.4 8.3
Current Liabilities
Account Payables 6.8 11.8 9.0 7.3 6.3 6.7 7.9 3.6 4.7 5.3 12.6 8.5 5.2 5.6 16.2 1.1 1.6 5.1 2.6 0.9 1.5 3.6 2.4
Short-Term Debt 0 0.4 0.6 0 0 0 0 0 0 0 0 0.4 0 0 0 0 2.9 4.2 5 5 5 5 16.7
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 6.4 14.5 27.0 9 4.2 1.8 7.2 4.6 3.5 2.2 5.8 2.4 2.0 3.1 3.6 0.2 1.3 0 1.4 4.9 0 0 0
Total Current Liabilities 30.4 31.1 36.6 26.7 20.6 18.7 23.3 25.5 20.3 14.9 21.4 14.4 9.7 10.0 22.6 1.5 6.4 12.7 13.4 12.7 11.5 13.8 24.9
Non-Current Liabilities
Long-Term Debt 59.3 29.4 1.3 28.9 28.7 28.5 28.3 0 0 0 0 0 0 0 0 0 0 0 0.4 1.6 2.9 4.1 5.0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 29.2 0.0 0 0 0 0 0 0 0 1.5 1.5 0 0 0 0 0 141.5 0.4 0.3 0.3 0.4
Total Non-Current Liabilities 60.5 30.6 30.4 30.3 30.3 30.2 29.9 1.7 1.1 1.3 1.4 3.1 3.3 0.9 1.0 0 0 0 143.2 2.0 3.2 4.4 5.3
Total Liabilities 90.9 61.8 67.1 57.1 50.9 48.9 53.2 27.2 21.4 16.1 22.9 17.5 13.0 10.9 23.6 1.5 6.4 12.7 156.6 14.7 14.7 18.2 30.2
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0.0 0.0 0.0 0.0
Retained Earnings (633.2) (573.7) (510.2) (449.7) (387.3) (332.1) (298.0) (268.5) (241.9) (215.6) (188.6) (165.1) (150.9) (135.0) (112.2) (210.3) (207.0) (199.9) (65.4) (166.9) (148.3) (131.9) (112.8)
Accumulated Other Comprehensive Income (1.6) (0.6) 1.0 0.7 0.3 0.5 0.3 0.7 (0.1) 0 0 0 0 0 (0.0) 0 0 0 0 0 0 0 0
Total Stockholders' Equity 644.2 688.4 739.8 573.4 614.2 660.4 443.6 468.0 488.8 338.1 345.1 359.0 371.2 232.9 176.6 104.6 106.9 111.6 (64.2) 140.9 157.7 171.2 (21.9)
Total Liabilities & Equity 735.1 750.2 806.9 630.5 665.1 709.3 496.8 495.1 510.2 354.2 368.0 376.5 384.2 243.8 200.2 106.0 113.3 124.3 92.4 155.5 172.4 189.4 8.3
Debt Metrics
Total Debt 60.9 31.1 1.9 31.0 30.9 30.6 30 1.8 1.8 2.0 2.1 2.0 2.1 1.3 1.3 0 2.9 4.2 7.1 6.6 7.9 9.1 21.6
Net Debt (37.8) (57.9) (89.3) (109.7) (96.4) (92.0) (162.4) (190.8) (278.8) (340.6) (358.3) (368.6) (375.5) (235.2) (193.3) (101.7) (105.7) (114.9) (81.0) (143.4) (159.6) (175.9) 17.1
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Operating Activities
Net Income (59.5) (63.5) (60.5) (62.3) (55.2) (34.1) (29.5) (26.6) (26.4) (26.9) (23.6) (14.1) (15.9) (22.8) (21.2) (16.1) (9.6) (9.9) (17.8) (18.6) (16.4) (19.0) (14.3) (10.0) (6.8) (9.7)
Depreciation & Amortization 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Stock-Based Compensation 13.9 11.9 10.0 9.5 8.4 6.4 4.3 4.3 4.1 4.1 1.9 1.3 1.3 1.0 0 0.4 0.4 0.3 0 1.7 2.9 1.6 0.6 0.2 0.1 0.1
Change in Working Capital 1.4 (10.0) 8.4 6.3 0.3 (7.8) (2.8) 7.4 7.2 (10.9) 5.2 6.2 0.3 (13.8) 11.7 0.0 2.4 (4.2) 3.1 0.7 (2.4) (0.1) 0.4 0.9 (0.5) (0.4)
Other Non-Cash Items (0.1) (0.7) (1.3) (1.4) (1.5) (5.9) 0.4 (2.5) (0.4) 0.1 (1.4) (0.8) 1.6 0.1 (3.2) 6.0 (2.4) (0.0) 34.1 0.0 0.0 2.5 4.4 2.0 0.0 0.1
Operating Cash Flow (44.2) (62.2) (43.3) (47.8) (47.9) (41.4) (27.6) (17.4) (15.4) (33.6) (17.8) (7.5) (12.7) (35.5) (12.4) (9.7) (9.2) (13.7) 19.5 (16.1) (15.9) (15.0) (8.9) (6.9) (7.0) (9.9)
Investing Activities
Capital Expenditure 0 0 (0.0) (0.0) (0.0) (0.9) (0.4) 0.0 0.0 (0.1) (0.0) (0.0) (0.0) (0.0) (0.2) (0.0) (0.0) (0.1) (0.0) (0.1) 0 0 0 (0.0) 0 0
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (92.7) (93.8) (358.3) (85.4) (58.6) (347.2) (72.8) (94.1) (219.8) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 114.4 152.1 135.4 135 110.4 75.5 71.8 23 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow 21.6 58.3 (222.9) 49.5 51.7 (272.6) (1.4) (71.1) (219.7) (0.1) (0.0) (0.0) (0.0) (0.0) (0.2) (0.0) (0.0) (0.1) (0.0) (0.1) (0.0) (0.0) 0 (0.0) 0 0
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 27.6 0 0 0 0 0 0 0 5.4 (2.9) (1.2) (1.2) 3.3 (1.2) (1.2) (0.8) 0 14 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 30.0 0.7 0.6 0 0 10.2 0.4 0.6 0.6 1.1 0.8 0.6 10.5 28.5 95.3 2.9 1.3 1.3 (195.9) 0 (0.4) 196.3 0.1 0 0.0 0.0
Financing Cash Flow 32.3 1.7 216.7 11.6 0.9 244.3 28.8 0.4 173.2 15.9 7.8 0.5 153.9 77.3 154.3 0.0 0.1 0.1 (102.7) (1.2) (1.6) 195.5 0.1 14.0 0.0 20.1
Cash Position
Net Change in Cash 9.8 (2.2) (59.5) 13.3 4.7 (69.8) (0.2) (88.0) (62.0) (17.8) (10.0) (7.1) 141.1 41.8 93.1 (9.7) (9.1) (13.7) (61.9) (17.4) (17.5) 180.5 (8.7) 1.4 (7.0) 10.2
Cash at Beginning 89.2 91.4 140.7 127.6 122.9 192.7 192.9 280.9 342.9 360.6 370.7 377.7 236.6 194.8 101.7 65.3 74.5 88.2 150.1 167.8 185.3 4.8 13.5 0.0 13.5 3.3
Cash at End 98.9 89.2 81.2 140.9 127.6 122.9 192.7 192.9 280.9 342.9 360.6 370.7 377.7 236.6 194.8 55.6 65.3 74.5 88.2 150.4 167.8 185.3 4.8 1.4 6.5 13.5
Free Cash Flow (44.2) (62.2) (43.3) (47.8) (48.0) (42.2) (28.0) (17.4) (15.4) (33.7) (17.8) (7.5) (12.7) (35.5) (12.6) (9.7) (9.2) (13.8) 19.5 (16.2) (15.9) (15.0) (8.9) (7.0) (7.0) (9.9)
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (65.1) (69.5) (67.0) (67.7) (61.4) (39.9) (34.5) (32.9) (30.9) (31.5) (29.7) (19.0) (17.3) (25.1) (21.3) (10.5) (12.0) (10.0) (17.7) (18.4) (16.3) (16.5) 7.1 (7.9) (6.7) (9.6)
Net Income (59.5) (63.5) (60.5) (62.3) (55.2) (34.1) (29.5) (26.6) (26.4) (26.9) (23.6) (14.1) (15.9) (22.8) (21.2) (16.1) (9.6) (9.9) (17.8) (18.6) (16.4) (19.0) 9.2 (10.0) (6.8) (9.7)
EPS (Diluted) -1.54 -1.65 -1.64 -1.77 -1.58 -1.02 -0.98 -0.89 -1.03 -1.09 -1.00 -0.58 -0.74 -1.20 -21.23 -16.82 -10.14 -10.67 -6.97 -4.30 -3.82 -5.95 -0.20 -6.44 -4.36 -6.27
Balance Sheet
Cash & Equivalents 98.7 88.9 91.1 140.7 127.3 122.7 192.4 192.6 280.7 342.6 360.4 370.5 377.6 236.4 194.6 101.7 108.7 119.1 88.0 150.1 167.5 185.0 4.5
Total Assets 735.1 750.2 806.9 630.5 665.1 709.3 496.8 495.1 510.2 354.2 368.0 376.5 384.2 243.8 200.2 106.0 113.3 124.3 92.4 155.5 172.4 189.4 8.3
Total Debt 60.9 31.1 1.9 31.0 30.9 30.6 30 1.8 1.8 2.0 2.1 2.0 2.1 1.3 1.3 0 2.9 4.2 7.1 6.6 7.9 9.1 21.6
Stockholders' Equity 644.2 688.4 739.8 573.4 614.2 660.4 443.6 468.0 488.8 338.1 345.1 359.0 371.2 232.9 176.6 104.6 106.9 111.6 (64.2) 140.9 157.7 171.2 (21.9)
Cash Flow
Operating Cash Flow (44.2) (62.2) (43.3) (47.8) (47.9) (41.4) (27.6) (17.4) (15.4) (33.6) (17.8) (7.5) (12.7) (35.5) (12.4) (9.7) (9.2) (13.7) 19.5 (16.1) (15.9) (15.0) (8.9) (6.9) (7.0) (9.9)
Capital Expenditure 0 0 (0.0) (0.0) (0.0) (0.9) (0.4) 0.0 0.0 (0.1) (0.0) (0.0) (0.0) (0.0) (0.2) (0.0) (0.0) (0.1) (0.0) (0.1) 0 0 0 (0.0) 0 0
Free Cash Flow (44.2) (62.2) (43.3) (47.8) (48.0) (42.2) (28.0) (17.4) (15.4) (33.7) (17.8) (7.5) (12.7) (35.5) (12.6) (9.7) (9.2) (13.8) 19.5 (16.2) (15.9) (15.0) (8.9) (7.0) (7.0) (9.9)